Evaluate the Safety of GABITRIL in Adults With Generalized Anxiety Disorder
- Conditions
- General Anxiety Disorder
- Registration Number
- NCT00233675
- Lead Sponsor
- Cephalon
- Brief Summary
To assess the long-term safety and tolerability of tiagabine treatment in patients with generalized anxiety disorder (GAD).
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- Not specified
Not provided
Not provided
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- SINGLE_GROUP
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (26)
Pivotal Research Center
🇺🇸Mesa, Arizona, United States
Southwestern Research
🇺🇸Beverly Hills, California, United States
Pharmacology Research Institut
🇺🇸Northridge, California, United States
Pacific Clinical Research Medi
🇺🇸Orange, California, United States
Radiant Research San Diego
🇺🇸San Diego, California, United States
Affiliated Research Institute
🇺🇸San Diego, California, United States
Radiant Research Denver
🇺🇸Denver, Colorado, United States
University of Connecticut
🇺🇸Farmington, Connecticut, United States
Clinical Neuroscience Solution
🇺🇸West Palm Beach, Florida, United States
Carman Research
🇺🇸Smyrna, Georgia, United States
Scroll for more (16 remaining)Pivotal Research Center🇺🇸Mesa, Arizona, United States